Most Popular
-
1
No plan to let doctors with foreign licenses practice here anytime soon: PM
-
2
Ador CEO's dismissal to be decided on last day of May
-
3
[Graphic News] Beer the most favored alcoholic drink by Koreans
-
4
Science Ministry expresses regret over Japan’s pressure on Naver
-
5
Haeundae Beach to become sand art museum in late May
-
6
Medical professors set to take day off amid protracted walkouts by junior doctors
-
7
Hostilities get out of hand as YouTuber murders another outside courthouse
-
8
Police officer jumps barefoot into drainage tunnel to save man
-
9
Lee Sun-kyun's posthumuous film to hit theaters in August
-
10
State-led adoption system to be established to ensure adoptees' well-being, minimize overseas adoption
-
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial
Positive primary endpoint result of objective response rate (ORR) from the planned interim analysis of Phase II trial in advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJ). Top-line data of the final analysis from Phase II to be announced in the second half of next year. SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEOs: Pae, Jisoo, Park, Hansoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT0541936
May 20, 2023
-
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023
- New investigational data evaluating Fexuprazan in a Korean clinical trial program for healing erosive esophagitis (EE) regardless of food intake, and in a Chinese pivotal clinical trial program for the treatment of EE SEOUL, South Korea and CHICAGO, May 19, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 19th that they set up a booth at the Digestive Disease Week® 2023 (DDW 2023) held in Chicago, USA and revealed new clinical data
May 20, 2023
-
Mlytics Unveils AI-Powered Conversational Chatbot, Revolutionizing Customer Experience
SINGAPORE, May 19, 2023 /PRNewswire/ -- Mlytics, a company focused on web optimization solutions and augmenting technology video stream companies, is introducing a new addition to their platform, a GPT-powered Mlytics AI Assistant. This development is not meant to be a new commodity, but rather an embodiment of Mlytics' dedication to improving the user's digital experience on their platform. The Mlytics AI Assistant provides real-time, personalized assistance, facilitating immediate respo
May 20, 2023
-
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease
Tanfanercept did not demonstrate statistical significance in either of the primary outcome measures of improvement in central corneal staining score (CCSS) or in improvement in Eye Dryness Score (EDS) assessed at week 8 in subjects with dry eye disease (DED), compared to vehicle. However, tanfanercept did demonstrate a highly statistically significant improvement on one of the secondary outcome measures, Schirmer testing of tear volume. Tanfanercept demonstrated a similar safety profile
May 19, 2023
-
HKEX to Launch HKD-RMB Dual Counter Model on 19 June 2023
HKD-RMB Dual Counter Model to be launched in Hong Kong securities market on 19 June 2023, subject to market readiness HKEX now accepting applications for Dual Counter Market Makers HONG KONG, May 19, 2023 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) is today (Friday) pleased to announce that it will launch the Hong Kong Dollar (HKD)-Renminbi (RMB) Dual Counter Model (Model) and the Dual Counter Market Making Programme in its securities market on 19 June 2023, subject t
May 19, 2023
-
Appier was awarded the 'Best Talent Acquisition Team'
Appier's talent-driven approach: Empowering growth in the competitive AI market through strong recruitment and retention efforts TAIPEI, May 19, 2023 /PRNewswire/ -- Appier, a leading software-as-a-service (SaaS) company that uses artificial intelligence (AI) to power business decision-making, is proud to announce that it was awarded the 'Best Talent Acquisition Team' and was also recognized as a 'Best Employer Brand' finalist at the recent 2022 LinkedIn Talent Awards. These two recognitions i
May 19, 2023
-
EQuest Raises US$120 Million and Welcomes New Board Member
HO CHI MINH CITY, Vietnam, May 19, 2023 /PRNewswire/ -- On 19 May 2023 EQuest Education Group announced the successful raising of US$120 million through a combination of debt from creditor, and equity from its existing investor KKR's Global Impact Fund. The proceeds will be utilized for the investment in the Canadian International School (CIS) System in Ho Chi Minh City, and to expand its College & University system, particularly the Broward College Vietnam campuses in Hanoi, Hue, and H
May 19, 2023
-
AMEC EARNS FIRST POSITION IN TWO RANKINGS OF TECHINSIGHTS CUSTOMER SATISFACTION SURVEY 2023
SHANGHAI, May 19, 2023 /PRNewswire/ -- Advanced Micro-Fabrication Equipment Inc. China (AMEC), a global micro-fabrication equipment Company serving customers in the semiconductor and adjacent high-tech sectors, is proud to announce that it has won six awards in the 2023 TechInsights Customer Satisfaction Survey (CSS). Most notably, AMEC has taken first place in"THE BEST Suppliers of Fab Equipment to Specialty Chip Makers and Deposition Equipment". CSS is conducted annually by TechInsig
May 19, 2023
-
Microsoft announces new AI solutions for Microsoft Cloud for Nonprofit: a game-changer for fundraising and volunteer engagement
SINGAPORE, May 19, 2023 /PRNewswire/ -- Microsoft Corp. announced a suite of new AI solutions and improvements to Microsoft Cloud for Nonprofit that are designed to transform the nonprofit industry and how fundraisers engage with donors, manage campaigns and optimize operations. In addition, the company announced a limited private preview for nonprofits to experience a new AI-powered fundraising propensity model. Within the preview, participating nonprofits will be able to test new AI tools
May 19, 2023
-
Northwest China's Xi'an opens air routes to all Central Asian countries
BEIJING, May 19, 2023 /PRNewswire/ -- A report from People's Daily: Xi'an, northwest China's Shaanxi province, opened an air route to Dushanbe, capital of Tajikistan, on May 18. It marked the 16th international passenger flight route currently in service in Xi'an. Today, a total of 11 flights flying each week between Xi'an and Central Asian destinations. At present, Xi'an becomes the only Chinese city that has opened air routes to all the five Central Asian countries. According to Zhang Xu
May 19, 2023
-
Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey
The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 19, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific Health Priority Survey, which revealed that a vast majority (77%) of consumers in the Asia Pacific region became more health conscious as a result of the COVID-19 pandemic. This sentiment
May 19, 2023
-
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)
- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three exosome companies in the world, announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for a cosmetic composition containing rose stem
May 19, 2023
-
PEI-Genesis Announces Opening of New Production Facility
New Facility in Philadelphia, PA, Provides D-Sub Connectors with Fast Lead Times to Customers PHILADELPHIA, May 19, 2023 /PRNewswire/ -- PEI-Genesis, a global leader in the design and assembly of custom engineered interconnect solutions, announced the opening of a new production site in Philadelphia, PA. This new facility will support the increasing demand for D-Subminiature connectors, arguably the most versatile interconnect product on the market. It will be utilized to supplement PEI's
May 19, 2023
-
SANY Heavy Industry and Shenglong Metallurgical Establish Strategic Partnership to Drive Green Transformation in Steel Industry
CHANGSHA, China, May 19, 2023 /PRNewswire/ -- SANY Heavy Industry ("SANY", SSE: 600031), a leading global heavy machinery manufacturer, recently held a signing ceremony during which the company reached a strategic partnership with Guangxi Shenglong Metallurgical Co Ltd (Shenglong Metallurgical). Liang Linhe, Chairman of SANY Heavy Truck, and Lin Nengjing, CEO of Shenglong Metallurgy, signed the strategic cooperation agreement on behalf of their respective companies. jwpl
May 19, 2023
-
CGTN: How to open up a new era of China, Central Asia cooperation
BEIJING, May 19, 2023 /PRNewswire/ -- China's General Administration of Customs published data on Wednesday, showing that China's import and export volume with Central Asian countries amounted to 173.05 billion yuan ($24.8 billion) in the first four months, an increase of 37.3 percent compared with the same period last year. It is particularly noteworthy that China's export and import volume with the five Central Asian countries, namely Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbe
May 19, 2023
-
Bangladesh Lifts Fumigation Requirements on U.S. Cotton Following CCI-Sponsored U.S. Cotton Tour
WASHINGTON, May 19, 2023 /PRNewswire/ -- A Cotton Council International (CCI)-sponsored Bangladesh Ministry of Agriculture Delegation's U.S. visit from Oct. 30-Nov. 5, 2022, coupled with indispensable efforts by the U.S. Department of Agriculture's (USDA) Foreign Agricultural Service (FAS) office in Dhaka, ultimately convinced the Bangladesh government to relax its nearly-five-decade-long fumigation requirement on U.S. cotton imports. This shift will remove a significant export barrier for U
May 19, 2023
-
Pylontech to Establish Its First Overseas Factory
SANT'ANGELO DI PIOVE DI SACCO, Italy, May 19, 2023 /PRNewswire/ -- Pylon Technologies Co., Ltd. ("Pylontech") announces its plan to build its first overseas factory in Italy at a press conference in Veneto on 18 May 2023. Pylon LiFeEU S.r.l., the joint venture based in Sant'Angelo di Piove di Sacco (PD) will result in Pylontech's first overseas factory to produce and deliver energy storage solutions in a more stable and secured way for customers in Europe. It's jointly owned by Pylon
May 19, 2023
-
Arasan Announces immediate availability of its SUREBOOT™ Total xSPI PHY IP
Arasan Chip Systems, a leading provider of semiconductor IP for mobile and automobile SoCs, today announced the immediate availability of its SUREBOOT™ Total xSPI IP Solution which now includes the xSPI PHY IP. SAN JOSE, Calif., May 18, 2023 /PRNewswire/ -- Arasan expands its solid state storage IP portfolio with the announcement of the immediate availability of its Total eXpanded Serial Peripheral Interface (xSPI) IP including xSPI PHY compliant to the JEDEC JESD251 xSPI Specification V1.0.
May 19, 2023
-
Smart NFT Owners Build Value, Have Fun and Earn Daily Rewards on VIMworld!
SAN FRANCISCO, May 18, 2023 /PRNewswire/ -- VIMworld is excited to announce that its SmartNFT Digital Companion ecosystem is open and users are actively building value, discovering fun ways to engage and earning daily rewards. While many NFT projects have suffered in this current market or have shut down completely, VIMworld is thriving by focusing on utility and operating with a next-gen mindset. Join VIMworld today to grow, compete and play. SmartNFTs Built for Everyday Ac
May 19, 2023
-
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA
- Flagship products Neurophet AQUA and Neurophet SCALE PET both received 510k - Plans to cooperate with radiology AI solution platform companies to enter the U.S. market SEOUL, South Korea, May 18, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that the US Food and Drug Administration (FDA) 510(k) has cleared "Neurophet AQUA". Neurophet receives FDA 510(k) Clearance for Neurophet AQUA Neurophet AQUA is
May 19, 2023